687 related articles for article (PubMed ID: 34075578)
1. Exacerbation of immune thrombocytopenia following COVID-19 vaccination.
Kuter DJ
Br J Haematol; 2021 Nov; 195(3):365-370. PubMed ID: 34075578
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 vaccination in patients with immune thrombocytopenia.
Visser C; Swinkels M; van Werkhoven ED; Croles FN; Noordzij-Nooteboom HS; Eefting M; Last-Koopmans SM; Idink C; Westerweel PE; Santbergen B; Jobse PA; Baboe F; ; Te Boekhorst PAW; Leebeek FWG; Levin MD; Kruip MJHA; Jansen AJG
Blood Adv; 2022 Mar; 6(6):1637-1644. PubMed ID: 34941989
[TBL] [Abstract][Full Text] [Related]
3. Effects of COVID-19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia.
Kaicker S; Martinko K; Bussel JB
Pediatr Blood Cancer; 2023 Jan; 70(1):e30051. PubMed ID: 36317671
[TBL] [Abstract][Full Text] [Related]
4. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.
Lee EJ; Cines DB; Gernsheimer T; Kessler C; Michel M; Tarantino MD; Semple JW; Arnold DM; Godeau B; Lambert MP; Bussel JB
Am J Hematol; 2021 May; 96(5):534-537. PubMed ID: 33606296
[No Abstract] [Full Text] [Related]
5. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome.
Medeiros D; Buchanan GR
J Pediatr; 1998 Sep; 133(3):334-9. PubMed ID: 9738712
[TBL] [Abstract][Full Text] [Related]
6. Platelet dropping, bleeding and new treatment requirements in ITP patients after inactivated COVID-19 vaccination.
Zhan XY; Chen H; Kong H; Meng T; Ye J; Liu Y; Ng MHL; Li L; Zhang Y; Huang J; Peng Q; Chen C; He Y; Yang M
Immunol Lett; 2023 Dec; 264():56-63. PubMed ID: 38006954
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
Lee EJ; Beltrami-Moreira M; Al-Samkari H; Cuker A; DiRaimo J; Gernsheimer T; Kruse A; Kessler C; Kruse C; Leavitt AD; Lee AI; Liebman HA; Newland AC; Ray AE; Tarantino MD; Thachil J; Kuter DJ; Cines DB; Bussel JB
Blood; 2022 Mar; 139(10):1564-1574. PubMed ID: 34587251
[TBL] [Abstract][Full Text] [Related]
8. Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 Vaccine.
Ratajczak-Enselme M; Mutoni GC; Desmeules J; Favet L; Ing Lorenzini K
Acta Haematol; 2023; 146(1):52-57. PubMed ID: 36327915
[TBL] [Abstract][Full Text] [Related]
9. A real-world study of immune thrombocytopenia management during the COVID-19 pandemic in the UK.
Rampotas A; Watson E; Burton K; Hill QA; Pavord S
Br J Haematol; 2022 Jan; 196(2):351-355. PubMed ID: 34448203
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).
Hong J; Bang SM; Mun YC; Yhim HY; Lee J; Lim HS; Oh D;
J Korean Med Sci; 2018 May; 33(19):e142. PubMed ID: 29736158
[TBL] [Abstract][Full Text] [Related]
11. Severe Hemorrhage in Chinese Children With Immune Thrombocytopenia.
Zhou F; Xu Y; Zhang Z; Wu X; Jin R
J Pediatr Hematol Oncol; 2015 Apr; 37(3):e158-61. PubMed ID: 25493457
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and predictors of treatment responses and complications in immune thrombocytopenia.
Ong SY; Tan CW; Ramya V; Malik AA; Lee XH; Hwang JCC; Yang Y; Ng HJ; Lee LH
Ann Hematol; 2021 Mar; 100(3):645-651. PubMed ID: 33515047
[TBL] [Abstract][Full Text] [Related]
13. Exacerbation of immune thrombocytopenia following initial and booster vaccination with Pfizer-BioNTech COVID-19 vaccine.
Aharoni M; Leader A; Shochat T; Raanani P; Spectre G
Platelets; 2022 Jul; 33(5):781-786. PubMed ID: 35536172
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience.
Kewan T; Gunaratne TN; Mushtaq K; Alayan D; Daw H; Haddad A
Transfusion; 2021 Jul; 61(7):2014-2018. PubMed ID: 33724474
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
Palau J; Sancho E; Herrera M; Sánchez S; Mingot ME; Upegui RI; Rodríguez Salazar MJ; de la Cruz F; Fernández MC; González López TJ; Hernández JJ; Ríos E; López-Fernández MF; García M; Hernández JÁ; Sanz MA
Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
17. Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China.
Zhou H; Fu R; Wang H; Zhou F; Li H; Zhou Z; Zhang L; Yang R
Ann Hematol; 2013 Jan; 92(1):79-87. PubMed ID: 22956151
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune thrombocytopenia: Current treatment options in adults with a focus on novel drugs.
Witkowski M; Witkowska M; Robak T
Eur J Haematol; 2019 Dec; 103(6):531-541. PubMed ID: 31449692
[TBL] [Abstract][Full Text] [Related]
19. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of chronic idiopathic thrombocytopenia in Chinese children.
Wong MS; Chan GC; Ha SY; Lau YL
J Pediatr Hematol Oncol; 2002 Nov; 24(8):648-52. PubMed ID: 12439037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
